Latest action: Referred to the House Committee on Financial Services.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill addressing financial services oversight in biotechnology and innovation sectors.
The problem
Unclear regulatory gaps may exist between financial oversight agencies and emerging biotechnology innovation activities requiring coordinated supervision.
The proposal
Establishes or modifies financial services committee jurisdiction over biotechnology and innovation sector financial activities and reporting requirements.
The impact
Financial institutions, biotechnology companies, and innovation investors face potential new compliance rules and reporting obligations under financial services oversight.
Establishing clear financial oversight can reduce confusion about which rules apply to biotech companies. This may help businesses understand their obligations better and operate more confidently in the sector.
Stronger financial services oversight can help protect investors from fraud and financial misconduct in biotech investments. Better regulations may increase confidence in this growing investment sector.
Clear financial frameworks can help biotech companies access funding more easily and grow faster. Well-defined rules make it easier for banks and investors to fund new projects.
New financial rules mean biotech companies must spend more money on lawyers, accountants, and compliance staff. Smaller companies may struggle with these added expenses.
Stricter financial oversight could make it harder and slower for biotech startups to get funding. Complex regulations might discourage new companies from starting or expanding.
The bill might create duplicate oversight between different government agencies. This could cause confusion and inefficiency rather than solving problems.
Without seeing the actual bill text, the specific rules and their real effects remain unclear. This makes it difficult to predict whether benefits will actually occur.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Other bills in this policy area
HR 10671
Securing Our Critical Infrastructure Act
HR 10695
United States Submarine Cable Security Policy Act of 2026
HR 7022
Mystic Alerts Act
S 5668
Methane Monitoring Science Act of 2026
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.